Athersys (ATHX) is a bio-pharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. ATHX is developing MultiStem(R), a patented adult-derived “off-the-shelf” stem cell product platform for multiple disease indications, including damage caused by myocardial infarction, bone marrow transplantation/oncology support, ischemic stroke and other indications. ATHX is also developing a portfolio of other therapeutic programs, including orally active pharmaceutical product candidates for the treatment of metabolic and central nervous system disorders, utilizing proprietary technologies, including Random Activation of Gene Expression (RAGE). (www.athersys.com)
Read more…
ACTC.OB or ACT is focused on developing and commercializing human stem cell technology. All of ACT’s technologies are at the basic research or in the pre-clinical stage of development, (www.advancedcell.com). Focus: ACT’s technologies are basic research or in the pre-clinical stage of development. ACT has 3 core research programs: Read more…
Referencing our previous 4 blogs; I thought I would back-up my posts with a few stem cell topic definitions (3 of 3 blogs); these were extrapolated from various websites and a sector report I have put together as well as excerpts from the International Society for Stem Cell Research.
Are some kinds of stem cells better than others?
Referencing our previous 3 blogs; I thought I would back-up my posts with a few stem cell topic definitions (2 of 3 blogs); these were extrapolated from various websites and a sector report I have put together as well as excerpts from the International Society for Stem Cell Research.
What is a stem cell line? Read more…
Referencing our previous 2 blogs; I thought I would back-up my posts with a few stem cell topic definitions (1 of 3 blogs); these were extrapolated from various websites and a sector report I have put together as well as excerpts from the International Society for Stem Cell Research.
What are stem cells?
Read more…
Stem cell technologies are anticipated to provide the stimulus for cellular repair or regeneration. This can be achieved in different ways: by administering stem cells, or specific cells that are derived from stem cells in the laboratory or by administering drugs that coax stem cells that are already present in tissues to more efficiently repair the involved tissue.
Read more…
Stem cells are the foundation cells for every organ, tissue and cell in the body and can be used to generate healthy and functioning specialized cells, which can then replace diseased or dysfunctional cells. Stem cells can treat debilitating diseases like Alzheimer’s disease, cancer, Parkinson’s disease, type-1 diabetes, spinal cord injury, stroke, burns, heart disease, osteoarthritis and rheumatoid arthritis. Stem cells can serve as an alternative and renewable source for specialized cells. We believe that the stem cell companies have accumulated the requisite reproductive biology and tissue culture expertise to develop human therapeutics.
Read more…
